Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell
Carcinoma Page 1 Prognostic Factors for Survival in Previously Treated Patients With …

Metastatic renal cell carcinoma (RCC) has a poor overall survival. Localized RCC remains a
surgical disease. About 20%-30% patients who present with limited disease at the time of …

Purpose: To identify prognostic factors and a model predictive for survival in patients w ith
metastatic renalcell carcinoma (RCC). Patients and Methods: The relationship betw een …

BACKGROUND. The majority of metastatic renal cell carcinoma (mRCC) clinical trials that
examined targeted agents used progression‐free survival (PFS) as the primary endpoint …

Prognostic and predictive factors in patients with metastatic renal cell carcinoma (MRCC)
have been evaluated from untreated patients or patients on several different treatment …

A data base study of 610 patients with recurrent or metastatic renal cell carcinoma was
conducted in order to identify clinical characteristics that are prognostic for survival in …

Renal cell carcinoma is the 14th most common cancer worldwide. It is a heterogeneous
group of histopathological entities, of which the most common is clear cell renal cell …

Opinion statement Patients with renal cell cancer (RCC) develop metastatic spread in
approximately 33% of cases. The clinical management of patients with metastatic RCC is …

In the US and Europe, clinical practice guidelines for metastatic renal cell carcinoma have
undergone several revisions as a result of the introduction of molecular‐targeted therapies …

Purpose: Our understanding of the natural history of renal cell carcinoma, the role of
nephrectomy, the benefits of immunotherapy and the possibilities of new technologies are …